Dr. Rita D. Paschal, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of South Florida College of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 176
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of South Florida College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
FL license ME173786 · AL license 31860 -
Hematology (Internal Medicine) Physician
FL license ME173786 -
Medical Oncology Physician
FL license ME173786
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Medical Center - Jacksonville Jacksonville, FL
- Baptist Medical Center Beaches Jacksonville Beach, FL
- Baptist Medical Center - Nassau Fernandina Beach, FL
Medical groups
- Baptist MD Anderson Cancer Physicians Inc (119 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 176
- Services billed
- 318
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 133 | 96 |
| New patient office or other outpatient visit, 60-74 minutes | 34 | 34 |
| Established patient office or other outpatient visit, 10-19 minutes | 27 | 23 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 25 | 25 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 24 | 19 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 20 | 20 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 19 | 19 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 16 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Jacksonville, FL | 136 |
| Hydroxyurea Other prescribers in Jacksonville, FL | 128 |
| Promacta (eltrombopag olamine) | 33 |
| Prednisone Other prescribers in Jacksonville, FL | 31 |
| Jakafi (ruxolitinib phosphate) | 30 |
| Enoxaparin Sodium Other prescribers in Jacksonville, FL | 29 |
| Xarelto (rivaroxaban) Other prescribers in Jacksonville, FL | 27 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Jacksonville, FL | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $115 in total to this clinician.
| Octapharma USA, Inc. | $95.50 |
|---|---|
| Genzyme Corporation | $19.06 |
| Food and Beverage | $115 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $5,760 in research payments for these studies, mostly to the institutions running them.
- Cold Agglutinin Disease Real World Evidence Registry
Sanofi US Services Inc. · Active, not recruiting · NCT05791708
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.